NCCN Guidelines for Patients® | Myelodysplastic Syndromes
66 NCCN Guidelines for Patients ® : Myelodysplastic Syndromes, 2018 Dictionary side effect An unhealthy or unpleasant physical or emotional condition caused by treatment. subtype Smaller groups that a type of cancer is divided into based on certain features of the cancer cells. supportive care Treatment for the symptoms or health conditions caused by cancer or cancer treatment. symptom A new or changed health problem a person experiences that may indicate a disease. thrombocytopenia A condition in which there is a low number of platelets— blood cells that help control bleeding. transfusion A slow injection of whole blood or parts of blood into a vein. treatment response An outcome or improvement in disease that is caused by treatment. U.S. Food and Drug Administration (FDA) A federal government agency that regulates drugs and food. vitamin B12 A nutrient in the body that is needed to make red blood cells. white blood cell A type of blood cell that helps fight infections in the body. white blood cell growth factor A substance that causes new white blood cells to grow in the bone marrow. It is made naturally in the body but can also be made in a lab to use as treatment. WHO classification-based Prognostic Scoring System (WPSS) A system that doctors use to rate the severity of MDS and classify it into groups based on the likely outcome (prognosis).